Chemical Suppliers: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Company Introduction: INEOS Chlor is one of the major chlor-alkali producers in Europe and a global leader in chlorine derivatives. We are also a leading manufacturer of sulphur chemicals and a key player in the field of electrochemical technology. Product reliability is complemented by a strong focus on customer needs, and we place great emphasis on working alongside our customers in a partnership geared to preparing for future market and product demands.
Company Introduction: ALLAN CHEMICAL CORPORATION，Established in 1984, Allan Chemical Corporation is a supplier of high quality chemicals. Quality and service have been and continue to be our driving forces. Working with well respected partners, we are able to provide our customers with products meeting the ACS, USP and FCC compendia. Our products are sourced world-wide and warehoused locally for prompt shipment. We can also have products specially produced to meet any special needs you may have.
Company Introduction: Eastman manufactures and markets chemicals, fibers and plastics worldwide. We provide key differentiated coatings, adhesives and specialty plastics products. We're the world's largest producer of PET polymers for packaging and a major supplier of cellulose acetate fibers. Founded in 1920 and headquartered in Kingsport, Tennessee, Eastman is a FORTUNE 500 company with 2005 sales of $7 billion and approximately 12,000 employees. We produce over 1,200 products that enhance the lives of people worldwide. Even though our products are not household words, they are used in making everything from the packaging for your food, drinks and personal care products, to the fabric in your clothing and home furnishings, to the paint on your house and automobile, to the plastics on your bicycle helmet and golf clubs.
Company Introduction: Par Pharmaceutical Companies, Inc. develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In July 2005, Par received approval for and introduced Megace ES, the company's first branded pharmaceutical product. We expect to launch our second branded product some time in 2006. Our Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par ranks fifth in sales among all U.S. generic companies, according to IMS Health. We currently manufacture, market, or license more than 110 prescription drug products. Par has 59 products awaiting FDA approval and more than 60 other products in various stages of development. In 2005 the company completed the integration of Kali Laboratories, Inc. into the Par structure, which significantly increased Par's generic research and development capabilities. With the acquisition and integration of Kali Laboratories, Par now has one of the most promising new product pipelines in the generic drug industry. Par's generic drug portfolio includes central nervous system, cardiovascular, anti-inflammatory, gastrointestinal, and anti-infective therapeutics. The company has focused on developing products with limited competition and longer life cycles. Par's strategy of aggressive business development, including creative alliances and acquisitions, has successfully complemented its steadily increasing investment in internal research and development. Par encourages innovation among its employees, in its relationships with partners and customers, and in the ways the Company approaches future opportunities. We take pride in our business agility and ingenuity. We have built novel relationships with a range of partner companies, helping us to bring high-quality products to our customers and to patients quickly and cost-effectively in the rapidly evolving US pharmaceutical marketplace. Detailed information about Par Pharmaceutical Companies, Inc. (NYSE: PRX) for investors and for the media is provided elsewhere on this web site. A current "fact sheet" about Par is also available.
Company Introduction: MacKenzie Co LLC originally began as MacKenzie Chemical Works Inc. was founded by Ian MacKenzie. Putting his entrepreneurial spirit together with his chemical engineering experience, he began building a company that would produce useful chemicals for unique markets. His patented fuel oil combustion catalyst, "PYROCAT", used many of the metal acetylacetonates we still manufacture today. This facility was built in 1977.,The company turned more to the synthesis of chemical compounds rather than blending formulations. This involved investment in costly manufacturing systems and research by a growing technical staff.,In the 70's and 80's specialized products were developed for the imaging industry. The company expanded rapidly in people, equipment and sales.,In the 90's and now into the new millennium the company has again established a reputation for quality products and dependability. In 2001 Ian MacKenzie sold the business to a group of experienced chemical company executives including Martin Lapari now President and Bob Bowers who managed the business for Ian for many years. The company's extensive line of products, R&D, scale-up, toll manufacturing ... whatever your needs, our "know how" and "can do" attitude can help you.